Therapeutic options for newly diagnosed multiple myeloma
10.3760/cma.j.issn.1009-9921.2008.05.030
- VernacularTitle:新诊断的多发性骨髓瘤的治疗选择
- Author:
Jian HOU
;
Jianling FAN
- Publication Type:Journal Article
- Keywords:
Multiple myeloma;
Therapy;
Stem cell transplantation
- From:
Journal of Leukemia & Lymphoma
2008;17(5):389-391
- CountryChina
- Language:Chinese
-
Abstract:
According to the latest classification of International Myeloma Working Group(IMWG),multiple myeloma(MM)is roughly classified into two groups,asymptomatic myeloma(smoldering myeloma)and symptomatic myeloma.The former is equal to the stage Ⅰ of Durie-Salmon(DS),and patients of this type only wait and see,and do not need any therapy.The later is equal to stage Ⅱ and Ⅲ of DS,and patients of this type need therapy immediately.Autologous stem cell transplantation(ASCT)is recommended by National Comprehensive Cancer Network(NCCN)for patients with stage Ⅱ or Ⅲ myeloma with good performance status in 2007.Different therapeutic regiwen should he selected for newly diagnosed MM patients according to whether ASCT is suitable or not.
